Inventor · disambiguated record
Steven S. Gross
Also filed as: GROSS STEVEN · GROSS STEVEN S
25 granted patents·2 pending applications·1,116 citations·filing 1989–2018
97Inventor score
Files withCORNELL RES FOUNDATION INC9UNIV TEXAS8WISCONSIN MED COLLEGE INC2GROSS STEVEN1IMMUNIVEST CORP1
Top patents by PatentIndex Score
27 records- 0196US5646001AAffinity-binding separation and release of one or more selected subset of biological entities from a mixed population thereofIMMUNIVEST CORP·Filed 1995·Granted Jul 8, 1997·275 cites·38 claims
- 0295US7863012B2Analysis of circulating tumor cells, fragments, and debrisVERIDEX LLC·Filed 2004·Granted Jan 4, 2011·134 cites·16 claims
- 0394US8329422B2Analysis of circulating tumor cells, fragments, and debrisRAO GALLA CHANDRA·Filed 2010·Granted Dec 11, 2012·81 cites·17 claims
- 0493US6231894B1Treatments based on discovery that nitric oxide synthase is a paraquat diaphoraseUNIV DUKE·Filed 1999·Granted May 15, 2001·107 cites·36 claims
- 0586US5028627AMethod of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factorCORNELL RES FOUNDATION INC·Filed 1989·Granted Jul 2, 1991·91 cites·43 claims
- 0685US5877176ABlocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesisCORNELL RES FOUNDATION INC·Filed 1993·Granted Mar 2, 1999·43 cites·18 claims
- 0782US5502050ABlocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesisCORNELL RES FOUNDATION INC·Filed 1993·Granted Mar 26, 1996·37 cites·6 claims
- 0880US5334380AAnti-endotoxin, interleukin-1 receptor antagonist and anti-tumor necrosis factor antibody with arginine-free formulations for the treatment of hypotensionUNIV TEXAS·Filed 1992·Granted Aug 2, 1994·58 cites·23 claims
- 0980US5216025ANitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patientsUNIV TEXAS·Filed 1991·Granted Jun 1, 1993·64 cites·27 claims
- 1079US6784178B2Pharmacotherapy for vascular dysfunction associated with deficient nitric oxide bioactivityCORNELL RES FOUNDATION INC·Filed 2001·Granted Aug 31, 2004·12 cites·18 claims
- 1176US6153615ABlocking induction of tetrahydrobioterin to block induction of nitric oxide synthesisCORNELL RES FOUNDATION INC·Filed 1999·Granted Nov 28, 2000·28 cites·5 claims
- 1272US5286739AParenteral formulations for the inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factorUNIV TEXAS·Filed 1991·Granted Feb 15, 1994·35 cites·9 claims
- 1370US5374651AMethods and compositions for the treatment of hypotension with arginine free essential and essential amino acids and arginine derivativesUNIV TEXAS·Filed 1992·Granted Dec 20, 1994·36 cites·46 claims
- 1466US5874433ABlocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesisCORNELL RES FOUNDATION INC·Filed 1995·Granted Feb 23, 1999·19 cites·15 claims
- 1563US6967219B2Reversing or preventing premature vascular senescenceUNIV NEW YORK STATE RES FOUND·Filed 2002·Granted Nov 22, 2005·1 cites·11 claims
- 1662US6274581B1Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesisCORNELL RES FOUNDATION INC·Filed 1993·Granted Aug 14, 2001·25 cites·12 claims
- 1761US5880124ABlocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesisCORNELL RES FOUNDATION INC·Filed 1996·Granted Mar 9, 1999·13 cites·15 claims
- 1858US5395612AMethod for treating systemic hypotension caused by sepsis or cytokine using arginase in combination with an α1 adrenergic agonistCORNELL RES FOUNDATION INC·Filed 1991·Granted Mar 7, 1995·22 cites·5 claims
- 1956US9618515B2Assay to capture and detect circulating multiple myeloma cells from bloodGROSS STEVEN·Filed 2012·Granted Apr 11, 2017·1 cites·2 claims
- 2052US5723448APreventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproductionWISCONSIN MED COLLEGE INC·Filed 1996·Granted Mar 3, 1998·11 cites·13 claims
- 2152US5312835AUse of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotensionUNIV TEXAS·Filed 1992·Granted May 17, 1994·7 cites·4 claims
- 2250US5545625APreventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproductionWISCONSIN MED COLLEGE INC·Filed 1994·Granted Aug 13, 1996·11 cites·35 claims
- 2341US2002172987A1Methods and reagents for the rapid and efficient isolation of circulating cancer cellsFiled 2002·Application pending·0 cites
- 2439US2023059544A1Kits and assays to detect circulating multiple myeloma cells from bloodMENARINI SILICON BIOSYSTEMS SPA·Filed 2018·Application pending·0 cites
- 2538US5776979AMethod of use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotensionUNIV TEXAS·Filed 1995·Granted Jul 7, 1998·2 cites·2 claims
- 2634US5770623AArgine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factorUNIV TEXAS·Filed 1995·Granted Jun 23, 1998·2 cites·25 claims
- 2732US5534545AParenteral amino acid formulations for the inhibition of systemic hypotension associated with nitric oxide productionUNIV TEXAS·Filed 1993·Granted Jul 9, 1996·1 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Steven S. Gross files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →